title: How and when to use biologics in psoriasis.
authors: Mount Sinai Medical Center, NewYork, NY, USA. wedoderm@bellsouth.net
authors: Leon H
authors: LH
authors: Kircik
authors: Mercedes E
authors: ME
authors: Gonzalez
mesh_terms: D000077944:Alefacept; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use; D016903:Drug Monitoring; D006801:Humans; D011565:Psoriasis / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D001688:Biological Products; D003879:Dermatologic Agents; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha; D000077944:Alefacept